Read more

December 03, 2023
1 min read
Save

Neovascular AMD treatment in ‘last push’ of development; IOL positioning system launches

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.

Check out these items and more below.

Graphic distinguishing meeting news
Healio’s top video perspectives from Eyecelerator@AAO include a key update on sozinibercept for neovascular age-related macular degeneration and a launch announcement for the ZeptoLink IOL positioning system.

VIDEO: Sozinibercept in last push of phase 3 clinical development

Megan Baldwin, PhD, of Opthea shares an update on sozinibercept, a VEGF-C/D inhibitor for the treatment of neovascular age-related macular degeneration. Watch here.

VIDEO: Centricity Vision launches ZeptoLink IOL positioning system

Rob Thornhill of Centricity Vision announces the launch of the ZeptoLink IOL positioning system. Watch here.

VIDEO: Progressive pediatric myopia treatment at the tail end of phase 3 clinical trial

Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients. Watch here.

VIDEO: Bausch + Lomb rolls out new cataract, refractive technologies
of Bausch + Lomb overviews three recently launched refractive cataract technologies from the company. Watch here.

VIDEO: APX3330 shows promise in slowing diabetic retinopathy progression
George Magrath, MD, MBA, MS,
CEO of Ocuphire Pharma, provides an update on APX3330 for the treatment of diabetic retinopathy. Watch here.